期刊文献+

P_(16)蛋白在食管鳞状细胞癌的表达及临床意义 被引量:3

EXPRESSION OF P_(16) PROTEIN IN SQUAMOUS CELL CARCINOMA OF ESOPHAGUS AND ITS CLINICAL SIGNIFICANCE
暂未订购
导出
摘要 应用免疫络化S-P法检测88例食管浸润世鳞癌P16蛋白的表达,结果P16蛋白阳性率为55.68%(49/88),其阳性颗粒位于细胞浆内;组织学Ⅰ、Ⅱ、Ⅲ级阳性率分予的85.71%(18/21)、55.13%(16/29)、39.47%(15/38)(P<0.01);淋巴结转移组和无转移组阳世事分别为36.36%(12/33),67.27%(37/55)(P<0.01);3年生存率P16蛋白阳性组和阴性组分别36%和16.67%。结果表明食管鳞癌中P16蛋白的表达可以反映肿瘤的分化程度和转移情况.提示P16蛋白的检测可作为食管鳞癌的重要预后指标之一。 to study the expression of p16 protein in esphageal squamous cell carcima (escc) and itsclinicoodringical swificance, the ewion of p16 protein was analyzed by forstochedcal staining (s -p) using for - melin fixed, paraffin ededded sectbo of 88 cases with invasive squamous cell carioma of esoph-agus. expression of p16 protein was detected in 55. 68 % (49/88) of esccs. the opnaion wi correla ed withthe un histologc grade (grade 185. 71% (18/21), ii 55. 13% (16/29), iii39. 47% (15/38) (p <0.01) and lymph nede metastased) positive 36. 3% (12/33), negtive 67. 27% (37/55) (p <0.01). theresults suggst that the expression of p16 protein in rm an favorable prognosis of the lesion.
出处 《江苏临床医学杂志》 1998年第4期297-298,共2页 Journal of Jiangsu Clinical Medicine
关键词 食管肿瘤 P16蛋白 免疫组化 鳞状细胞癌 esophags neoplas p_(16) protein immunohistochemistry
  • 相关文献

参考文献1

二级参考文献2

  • 1赵坡,Pacific Association of Societies of Pathologists,1995年
  • 2胡颖川,中华医学会病理学会第六次全国学术会议,1995年

共引文献6

同被引文献23

  • 1Allred DC, Harvey JM, Berado M, et al. Prognostic and predictive factors in breast cancer by immunohistochemical analysis. Mod Pathol,1998, 11(2):155 ~ 168.
  • 2Slamon DJ, Clark GM, Wong SJ, et al. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science, 1987,235(4785): 177 ~ 184.
  • 3Dougall WC, Qian X, Peterson NC, et al. The new-oncogene: signal transduction pathways, transformation mechanisms and evolving therapies. Oncogene, 1994, 9(8): 2109 ~ 2113.
  • 4Lam KY, Tin L, Ma L. C-erbB-2 protein expression in oesophageal squamous epithelium from oesophageal squamous cell carcinomas, with special reference to histological grade of carcinoma and pre-invasive lesions. Eur J Surg Oncol, 1998,24(5) :431 ~ 435.
  • 5Kamb A, Gruis NA, Weaver-Feldhaus J, et al. A cell cycle reulator potentially involved in genesis ofmany tumour type. Science, 1994, 264(5157):436~440.
  • 6Bernard T, Jacques B, Helene L et al. Cathepsin D expression by cancer and stromal cells in breast cancer: an mmunohistochenical study of 1384 cases. Breast Cancer Res Treat, 1999;55:137~47
  • 7Hickcy. K, Grchan D, Reid IM et al. Expresssion of epidermal growth factor recetor and proliferating cell nuclear antigen predicts respomse of esophageal squamous cell carcinoma to chemoradiotheraphy. Cancer, 1994;74(6):1694~8
  • 8Xiao-Mei Zhang,Ming-Zhou Guo.The value of epigenetic markers in esophageal cancer[J].Frontiers of Medicine in China.2010(4)
  • 9James P. Hamilton,Fumiaki Sato,Bruce D. Greenwald,Mohan Suntharalingam,Mark J. Krasna,Martin J. Edelman,Austin Doyle,Agnes T. Berki,John M. Abraham,Yuriko Mori,Takatsugu Kan,Carmit Mantzur,Bogdan Paun,Suna Wang,Tetsuo Ito,Zhe Jin,Stephen J. Meltzer.Promoter Methylation and Response to Chemotherapy and Radiation in Esophageal Cancer[J].Clinical Gastroenterology and Hepatology.2006(6)
  • 10Kim S.Kraunz,Heather H.Nelson,MiriamLemos,John J.Godleski,John K.Wiencke,Karl T.Kelsey.Homozygous deletion of p16&lt;sup&gt;INK4a&lt;/sup&gt; and tobacco carcinogen exposure in nonsmall cell lung cancer[J].Int J Cancer.2006(6)

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部